148705-09-3 Usage
General Description
Gal beta(1-3)GlcNAc beta(1-3)Gal beta(1-4)Glc-beta-pNP is a chemical compound that consists of a complex carbohydrate structure linked to a chromogenic substrate, p-nitrophenyl. It is often used as a substrate in enzyme assays to study the activity of glycosyltransferases, which are enzymes involved in the synthesis of glycoproteins and glycolipids. The structure of the compound consists of specific sugar residues linked in a particular sequence, which makes it a useful tool for studying the substrate specificity and enzymatic activity of glycosyltransferases. The p-nitrophenyl group at the end of the compound allows for easy detection and quantification of the enzymatic reaction, making it a valuable tool in biochemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 148705-09-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,7,0 and 5 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 148705-09:
(8*1)+(7*4)+(6*8)+(5*7)+(4*0)+(3*5)+(2*0)+(1*9)=143
143 % 10 = 3
So 148705-09-3 is a valid CAS Registry Number.
InChI:InChI=1/C32H48N2O23/c1-10(39)33-17-27(56-31-23(45)21(43)18(40)13(6-35)52-31)19(41)14(7-36)51-29(17)57-28-20(42)15(8-37)53-32(25(28)47)55-26-16(9-38)54-30(24(46)22(26)44)50-12-4-2-11(3-5-12)34(48)49/h2-5,13-32,35-38,40-47H,6-9H2,1H3,(H,33,39)/t13-,14-,15-,16-,17-,18-,19+,20-,21-,22+,23-,24-,25-,26+,27+,28-,29-,30+,31-,32-/m0/s1
148705-09-3Relevant articles and documents
A convenient synthesis of lacto-N-biose I [β-D-Galp-(1 → 3)-β-D-GlcpNAc] linkd oligosaccharides from phenyl O-(tetra-O-acetyl-β-D-galactopyranosyl)-(1 → 3)-4,6-di-O-acetyl-2-deoxy-2-phthalmido-1-thio-β-D-glucopyranoside
Jain,Locke,Matta
, p. 165 - 176 (2007/10/02)
The synthesis of two tetrasaccharides and one trisaccharide containing lacto-N-biose I (β-D-Galp(1 → 3)-β-D-GlcpNAc) as their terminal unit was accomplished through development and utilization of a key glycosyl donor, namely, phenyl O-(2,3,4,6-tetra-O-ace